MARKET

TTOO

TTOO

T2 Biosystems
NASDAQ
5.11
+0.31
+6.46%
After Hours: 5.20 +0.09 +1.76% 18:15 06/14 EDT
OPEN
4.680
PREV CLOSE
4.800
HIGH
5.44
LOW
4.680
VOLUME
128.76K
TURNOVER
0
52 WEEK HIGH
70.00
52 WEEK LOW
2.600
MARKET CAP
87.21M
P/E (TTM)
-0.2854
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at TTOO last week (0603-0607)?
Weekly Report · 4d ago
Weekly Report: what happened at TTOO last week (0527-0531)?
Weekly Report · 06/03 09:00
Weekly Report: what happened at TTOO last week (0520-0524)?
Weekly Report · 05/27 09:00
T2 Biosystems regains compliance with Nasdaq rule on market value of listed securities
Healthcare T2 Biosystems regains compliance with Nasdaq rule on market value of listed securities. TTOO shares were trading pre-market on Wednesday. The biotechnology company was required to maintain a $35M market value for 30 consecutive days. Nasdaq says company has regained compliance with requirement.
Seeking Alpha · 05/22 13:19
T2 Biosystems Regains Compliance With Nasdaq
T2 Biosystems, Inc. Is a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes. The Company received written notice from the Nasdaq Stock Market on May 21, 2024. Nasdaq says the Company has regained compliance with the market value of listed securities requirement.
Benzinga · 05/22 13:13
T2 BIOSYSTEMS REGAINS COMPLIANCE WITH NASDAQ CONTINUED LISTING REQUIREMENTS
Reuters · 05/22 13:00
T2 Biosystems Regains Compliance with Nasdaq Continued Listing Requirements
T2 Biosystems, Inc. Is a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes. The Company received written notice from the Nasdaq on May 21, 2024 that it has regained compliance with the market value of listed securities.
Barchart · 05/22 08:00
Weekly Report: what happened at TTOO last week (0513-0517)?
Weekly Report · 05/20 09:00
More
About TTOO
T2 Biosystems, Inc. is an in vitro diagnostics company focused on the detection of sepsis-causing pathogens and antibiotic resistance genes. Its technology enables detection of pathogens, biomarkers and other abnormalities in a variety of unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum and urine, and can detect cellular targets at limits of detection as low as one colony forming unit per milliliter (CFU/mL). Its focus includes three areas: sepsis, bioterrorism, and Lyme disease. The Company's products include the T2Dx Instrument, the T2Bacteria Panel, the T2Candida Panel, the T2Resistance Panel, and the T2Biothreat Panel, and are powered by the T2 Magnetic Resonance (T2MR) technology. It also has an active pipeline of products, including the United States T2Resistance Panel, the Candida auris test, and the T2Lyme Panel. T2Dx Instrument is a fully automated instrument that is capable of running a range of diagnostic tests from patient samples.

Webull offers T2 Biosystems Inc stock information, including NASDAQ: TTOO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TTOO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TTOO stock methods without spending real money on the virtual paper trading platform.